Digital Health & AI Innovation Summit 2026 (DHAI)
Digital Health & AI Innovation Summit 2026 (DHAI)
Prepare for FDA’s Elsa by proactively identifying compliance gaps and strengthening quality documentation before regulators arrive for a stronger, more
A top-20 pharmaceutical company was conducting a Phase III breast cancer study in 16 countries across North America, Europe, and
A top-20 pharmaceutical company was planning a large Phase III trial of a new vaccine for a mosquitoborne viral disease.
Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.
Coverage Analysis Certification Training Coverage Analysis CertificationTM Training is a virtual training that offers up to 12 hours of continuing education
In this webinar, leaders from cancer centers and biopharma companies will discuss the operational and institutional hurdles sites face and what can be done to address them. The panel will explore practical strategies to reduce burden, improve collaboration, and create a better experience for research staff and patients alike.
Focus on research while Advarra enhances compliance, accelerates timelines, and optimizes technology for clinical trial management.
Mastering Inspection Readiness for FDA’s AI Tool Elsa